The Global Clinical Trial Materials and Supplies Market is expected grow at 5.8% CAGR through 2030. The clinical trial is a research analysis that states whether a medical therapy, approach, or gadget is efficient, safe, and beneficial for human use. Clinical trial supplies management is required for avoiding inventory expiration, oversupply, and overproduction. With the growing prices of drug detection, clinical trial supplies are gaining more significance. A clinical trial requires robust supply chain management of the drugs, acknowledging the strictness of the laws and the constraints of the infrastructure for the profitable performance of the clinical trials. Raising the extent of clinical trial studies together with the increasing difficulty in conduction of these trials is the principal driver of the market.
The global clinical trial supplies market is propelled by circumstances such as growing pharmaceutical and biopharmaceutical R&D investments and addition in many clinical trials. Besides, the pandemic condition all over the world has generated an evolution in the worldwide healthcare sector with the soaring requirement for resolutions to stop the COVID-19 contamination. Consequently, the leading corporations in the market are anticipated to increase their clinical trial campaigns, with the initiation of innovative ones, to discover the way out from the novel coronavirus.
The North America region dominated the clinical trial materials and supplies market in 2019. The uppermost share of North America is mainly credited to the growing technical developments, rising cases of tailored drugs, augmented difficulty of material supply procedures in clinical trials, increasing finance by corporations, and several administration initiatives to boost the number of clinical trials.
The Asia Pacific region is anticipated to exhibit rapid expansion in the course of the assessment period. Chiefly owing to the growing occurrence of many chronic illnesses in the region, a lower charge of executing a clinical trial than western countries, and growing government ventures to perform clinical trials. Besides, as a result of the rigorous rules for shipping clinical material, clinical supplies, and supply end-users are estimated to reinforce their domestic existence in these nations.
Clinical Trial Materials and Supplies Market Share Analysis, by Geography (2021)
The report titled “Clinical Trial Materials and Supplies Market - Global Market Share, Trends, Analysis and Forecasts, 2021-2031” wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global clinical trial materials and supplies market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.
The global clinical trial materials and supplies market is segmented on the basis of Service, Phase, Drug Type, Therapeutic Area, and Geography. By service segment, the market is divided into Manufacturing, and Packaging, Logistics and Distribution, Documentation, Quantitative Clinical development, and Clinical operations. Based on Phase segment the clinical trial materials and supplies market is divided into Phase I, Phase II, Phase III, Phase IV, and BA/BE Studies. Depending on drug type the market is divided into small-molecule drugs, and biologic drugs. On the basis of therapeutic area the market is segmented into Oncology, Neurological and Mental Disorders, Infectious and Immune System Diseases, Digestive System Diseases, Blood Disorders, and Other Therapeutic Areas.
Based on geography, the global Clinical Trial Materials and Supplies Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is sub-segmented into the United States, Canada and Rest of North America. Europe is sub-segmented into Germany, United Kingdom, Belgium, Spain, and Rest of Europe. Asia Pacific is sub-segmented into China, Japan, India, Indonesia, Australia, South Korea, Taiwan, and Rest of Asia Pacific. Middle East & Africa is sub-segmented into Saudi Arabia, the UAE, and Rest of Middle East & Africa. South America is sub-segmented into Brazil and Rest of South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment and would identify the segment of the company focusing on Clinical Trials. Further, market share of prominent companies in the global Clinical Trial Materials and Supplies Market would also be estimated.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, swot analysis, and research and development focus of all the clinical trial companies. The global Clinical Trial Materials and Supplies Market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products under the clinical trial materials and supplies business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global Clinical Trial Materials and Supplies market.
Major players active in the global clinical trial materials and supplies market are Bilcare Inc., Mayne Pharma Group Ltd., Capsugel Inc., Avomeen Analytical Services, Catalent Inc., Eurofins Scientific Inc., Biocair International Ltd., Almac Group Ltd, Intertek Group plc, Parexel International Corporation, Recipharm AB, and Thermo Fisher Scientific Inc.
Segmentation:
By Service:
By Phase:
By Drug Type:
By Therapeutic Area:
By Geography:
1. Introduction 1.1. Research Objectives 1.2. Report Assumptions 1.3. Research Methodology 1.4. Abbreviations 2. Preface 2.1. Market Definition 2.2. Report Scope and Market Segmentation 2.3. Research Highlights 3. Market Synopsis: Global Clinical Trial Materials & Supplies Market 4. Global Clinical Trial Materials & Supplies Market Qualitative Analysis 4.1. Ecosystem Analysis 4.1.1. Role of participants 4.1.2. Integration scenario 4.2. Trends 4.2.1. Market trends 4.2.2. Technology Trends 4.3. PESTEL Analysis (For 5 prominent countries) 4.4. Market Influencers 4.4.1. Driving Forces 4.4.2. Hindering Forces 4.4.3. Opportunities 4.5. Supply Demand Scenario 4.6. Rules & Regulations 5. Global Clinical Trial Materials & Supplies Market Analysis and Forecast, by Service 5.1. Overview and definitions 5.2. Key segment analysis 5.3. Global Clinical Trial Materials & Supplies Market Estimates (US$ Mn), by Service, 2018 – 2030 5.3.1. Manufacturing and Packaging 5.3.2. Logistics and Distribution 5.3.3. Documentation 5.3.4. Quantitative Clinical development 5.3.5. Clinical operations 6. Global Clinical Trial Materials & Supplies Market Analysis and Forecast, by Phase 6.1. Overview and definitions 6.2. Key segment analysis 6.3. Global Clinical Trial Materials & Supplies Market Estimates (US$ Mn), by Phase, 2018 – 2030 6.3.1. Phase I 6.3.2. Phase II 6.3.3. Phase III 6.3.4. Phase IV 6.3.5. BA/BE studies 7. Global Clinical Trial Materials & Supplies Market Analysis and Forecast, by Drug Type 7.1. Overview and definitions 7.2. Key segment analysis 7.3. Global Clinical Trial Materials & Supplies Market Estimates (US$ Mn), by Drug Type, 2018 – 2030 7.3.1. Small-molecule drugs 7.3.2. Biologic drugs 8. Global Clinical Trial Materials & Supplies Market Analysis and Forecast, by Therapeutic Area 8.1. Overview and definitions 8.2. Key segment analysis 8.3. Global Clinical Trial Materials & Supplies Market Estimates (US$ Mn), by Therapeutic Area, 2018 – 2030 8.3.1. Oncology 8.3.2. Neurological and Mental Disorders 8.3.3. Infectious and Immune System Diseases 8.3.4. Digestive System Diseases 8.3.5. Blood Disorders 8.3.6. Other Therapeutic Areas 9. Global Clinical Trial Materials & Supplies Market Analysis and Forecast, by Region 9.1. Overview and definitions 9.2. Key segment analysis 9.3. Global Clinical Trial Materials & Supplies Market Estimates (US$ Mn), by Region, 2018 – 2030 9.3.1. North America 9.3.2. Europe 9.3.3. Asia Pacific 9.3.4. Middle East & Africa 9.3.5. South America 10. North America Clinical Trial Materials & Supplies Market Analysis and Forecast 10.1. Overview and definitions 10.2. Key segment analysis 10.3. North America Clinical Trial Materials & Supplies Market Estimates (US$ Mn), by Service, 2018 – 2030 10.3.1. Manufacturing and Packaging 10.3.2. Logistics and Distribution 10.3.3. Documentation 10.3.4. Quantitative Clinical development 10.3.5. Clinical operations 10.4. North America Clinical Trial Materials & Supplies Market Estimates (US$ Mn), by Phase, 2018 – 2030 10.4.1. Phase I 10.4.2. Phase II 10.4.3. Phase III 10.4.4. Phase IV 10.4.5. BA/BE studies 10.5. North America Clinical Trial Materials & Supplies Market Estimates (US$ Mn), by Drug Type, 2018 – 2030 10.5.1. Small-molecule drugs 10.5.2. Biologic drugs 10.6. North America Clinical Trial Materials & Supplies Market Estimates (US$ Mn), by Therapeutic Area, 2018 – 2030 10.6.1. Oncology 10.6.2. Neurological and Mental Disorders 10.6.3. Infectious and Immune System Diseases 10.6.4. Digestive System Diseases 10.6.5. Blood Disorders 10.6.6. Other Therapeutic Areas 10.7. North America Clinical Trial Materials & Supplies Market Estimates (US$ Mn), Country, 2018 – 2030 10.7.1. The U.S. 10.7.2. Canada 10.7.3. Rest of North America 11. Europe Clinical Trial Materials & Supplies Market Analysis and Forecast 11.1. Overview and definitions 11.2. Key segment analysis 11.3. Europe Clinical Trial Materials & Supplies Market Estimates (US$ Mn), by Service, 2018 – 2030 11.3.1. Manufacturing and Packaging 11.3.2. Logistics and Distribution 11.3.3. Documentation 11.3.4. Quantitative Clinical development 11.3.5. Clinical operations 11.4. Europe Clinical Trial Materials & Supplies Market Estimates (US$ Mn), by Phase, 2018 – 2030 11.4.1. Phase I 11.4.2. Phase II 11.4.3. Phase III 11.4.4. Phase IV 11.4.5. BA/BE studies 11.5. Europe Clinical Trial Materials & Supplies Market Estimates (US$ Mn), by Drug Type, 2018 – 2030 11.5.1. Small-molecule drugs 11.5.2. Biologic drugs 11.6. Europe Clinical Trial Materials & Supplies Market Estimates (US$ Mn), by Therapeutic Area, 2018 – 2030 11.6.1. Oncology 11.6.2. Neurological and Mental Disorders 11.6.3. Infectious and Immune System Diseases 11.6.4. Digestive System Diseases 11.6.5. Blood Disorders 11.6.6. Other Therapeutic Areas 11.7. Europe Clinical Trial Materials & Supplies Market Estimates (US$ Mn), Country, 2018 – 2030 11.7.1. Germany 11.7.2. United Kingdom 11.7.3. Belgium 11.7.4. Spain 11.7.5. Rest of Europe 12. Asia Pacific Clinical Trial Materials & Supplies Market Analysis and Forecast 12.1. Overview and definitions 12.2. Key segment analysis 12.3. Asia Pacific Clinical Trial Materials & Supplies Market Estimates (US$ Mn), by Service, 2018 – 2030 12.3.1. Manufacturing and Packaging 12.3.2. Logistics and Distribution 12.3.3. Documentation 12.3.4. Quantitative Clinical development 12.3.5. Clinical operations 12.4. Asia Pacific Clinical Trial Materials & Supplies Market Estimates (US$ Mn), by Phase, 2018 – 2030 12.4.1. Phase I 12.4.2. Phase II 12.4.3. Phase III 12.4.4. Phase IV 12.4.5. BA/BE studies 12.5. Asia Pacific Clinical Trial Materials & Supplies Market Estimates (US$ Mn), by Drug Type, 2018 – 2030 12.5.1. Small-molecule drugs 12.5.2. Biologic drugs 12.6. Asia Pacific Clinical Trial Materials & Supplies Market Estimates (US$ Mn), by Therapeutic Area, 2018 – 2030 12.6.1. Oncology 12.6.2. Neurological and Mental Disorders 12.6.3. Infectious and Immune System Diseases 12.6.4. Digestive System Diseases 12.6.5. Blood Disorders 12.6.6. Other Therapeutic Areas 12.7. Asia Pacific Clinical Trial Materials & Supplies Market Estimates (US$ Mn), Country, 2018 – 2030 12.7.1. Japan 12.7.2. India 12.7.3. China 12.7.4. Australia 12.7.5. Rest of Asia Pacific 13. Middle East & Africa Clinical Trial Materials & Supplies Market Analysis and Forecast 13.1. Overview and definitions 13.2. Key segment analysis 13.3. Middle East & Africa Clinical Trial Materials & Supplies Market Estimates (US$ Mn), by Service, 2018 – 2030 13.3.1. Manufacturing and Packaging 13.3.2. Logistics and Distribution 13.3.3. Documentation 13.3.4. Quantitative Clinical development 13.3.5. Clinical operations 13.4. Middle East & Africa Clinical Trial Materials & Supplies Market Estimates (US$ Mn), by Phase, 2018 – 2030 13.4.1. Phase I 13.4.2. Phase II 13.4.3. Phase III 13.4.4. Phase IV 13.4.5. BA/BE studies 13.5. Middle East & Africa Clinical Trial Materials & Supplies Market Estimates (US$ Mn), by Drug Type, 2018 – 2030 13.5.1. Small-molecule drugs 13.5.2. Biologic drugs 13.6. Middle East & Africa Clinical Trial Materials & Supplies Market Estimates (US$ Mn), by Therapeutic Area, 2018 – 2030 13.6.1. Oncology 13.6.2. Neurological and Mental Disorders 13.6.3. Infectious and Immune System Diseases 13.6.4. Digestive System Diseases 13.6.5. Blood Disorders 13.6.6. Other Therapeutic Areas 13.7. Middle East & Africa Clinical Trial Materials & Supplies Market Estimates (US$ Mn), Country, 2018 – 2030 13.7.1. Saudi Arabia 13.7.2. UAE 13.7.3. Rest of Middle East 14. South America Clinical Trial Materials & Supplies Market Analysis and Forecast 14.1. Overview and definitions 14.2. Key segment analysis 14.3. South America Clinical Trial Materials & Supplies Market Estimates (US$ Mn), by Service, 2018 – 2030 14.3.1. Manufacturing and Packaging 14.3.2. Logistics and Distribution 14.3.3. Documentation 14.3.4. Quantitative Clinical development 14.3.5. Clinical operations 14.4. South America Clinical Trial Materials & Supplies Market Estimates (US$ Mn), by Phase, 2018 – 2030 14.4.1. Phase I 14.4.2. Phase II 14.4.3. Phase III 14.4.4. Phase IV 14.4.5. BA/BE studies 14.5. South America Clinical Trial Materials & Supplies Market Estimates (US$ Mn), by Drug Type, 2018 – 2030 14.5.1. Small-molecule drugs 14.5.2. Biologic drugs 14.6. South America Clinical Trial Materials & Supplies Market Estimates (US$ Mn), by Therapeutic Area, 2018 – 2030 14.6.1. Oncology 14.6.2. Neurological and Mental Disorders 14.6.3. Infectious and Immune System Diseases 14.6.4. Digestive System Diseases 14.6.5. Blood Disorders 14.6.6. Other Therapeutic Areas 14.7. South America Clinical Trial Materials & Supplies Market Estimates (US$ Mn), Country, 2018 – 2030 14.7.1. Brazil 14.7.2. Rest of South America 15. Competition Analysis – Clinical Trial Materials & Supplies Market 15.1. Market Composition 15.2. Market Share Analysis (%), by Supplier (2019) 15.3. Company Profiles 15.3.1. Bilcare Inc. 15.3.1.1. Business overview 15.3.1.2. Management 15.3.1.3. Geographic presence 15.3.1.4. Product portfolio 15.3.1.5. Financial facts 15.3.1.6. Channel partners 15.3.1.7. Relevant news and strategic view 15.3.2. Mayne Pharma Group Ltd. 15.3.3. Capsugel Inc. 15.3.4. Avomeen Analytical Services 15.3.5. Catalent Inc. 15.3.6. Eurofins Scientific Inc. 15.3.7. Biocair International Ltd. 15.3.8. Almac Group Ltd 15.3.9. Intertek Group plc 15.3.10. Parexel International Corporation 15.3.11. Recipharm AB 15.3.12. Thermo Fisher Scientific Inc. 16. Conclusion & Recommendations
The Clinical Trial Materials and Supplies market has been assessed for the years 2022 to 2032.
Key Clinical Trial Materials and Supplies market players are Bilcare Inc., Mayne Pharma Group Ltd., Capsugel Inc., Avomeen Analytical Services, Catalent Inc., Eurofins Scientific Inc., Biocair International Ltd., Almac Group Ltd, Intertek Group plc, Parexel International Corporation, Recipharm AB, and Thermo Fisher Scientific Inc.
The global Clinical Trial Materials and Supplies market segmented on the basis of By Service, By Phase, By Drug Type, By Therapeutic Area and By Geography
North America is the principal contributor to the global Clinical Trial Materials and Supplies market.
Copyright © 2023 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved